Common Contracts
4 similar Warrant Agreement contracts by T2 Biosystems, Inc.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF T2 BIOSYSTEMS, INC. Dated as of December 30, 2016 Void after the date specified in Section 8Warrant Agreement • March 15th, 2017 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS CERTIFIES THAT, for value received, CRG PARTNERS III PARALLEL FUND "B" (CAYMAN) L.P. or its registered assigns (the “Holder”), is entitled, subject to the provisions and upon the terms and conditions set forth herein, to purchase from T2 Biosystems, Inc., a Delaware corporation (the “Company”), shares of the Company’s common stock, par value $0.001 per share (the “Shares”), in the amounts, at such times and at the price per share set forth in Section 1. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. This Warrant is issued in connection with the transactions described in the Term Loan Agreement, dated as of December 30, 2016 (the “Term Loan Agreement”), by and between the Company, the Subsidiary Guarantors from time to time party thereto, the Lenders from time to time party thereto and CRG Servicing LLC.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF T2 BIOSYSTEMS, INC. Dated as of December 30, 2016 Void after the date specified in Section 8Warrant Agreement • March 15th, 2017 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS CERTIFIES THAT, for value received, CRG PARTNERS III L.P. or its registered assigns (the “Holder”), is entitled, subject to the provisions and upon the terms and conditions set forth herein, to purchase from T2 Biosystems, Inc., a Delaware corporation (the “Company”), shares of the Company’s common stock, par value $0.001 per share (the “Shares”), in the amounts, at such times and at the price per share set forth in Section 1. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. This Warrant is issued in connection with the transactions described in the Term Loan Agreement, dated as of December 30, 2016 (the “Term Loan Agreement”), by and between the Company, the Subsidiary Guarantors from time to time party thereto, the Lenders from time to time party thereto and CRG Servicing LLC.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF T2 BIOSYSTEMS, INC. Dated as of December 30, 2016 Void after the date specified in Section 8Warrant Agreement • March 15th, 2017 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS CERTIFIES THAT, for value received, CRG PARTNERS III – PARALLEL FUND “A” L.P. or its registered assigns (the “Holder”), is entitled, subject to the provisions and upon the terms and conditions set forth herein, to purchase from T2 Biosystems, Inc., a Delaware corporation (the “Company”), shares of the Company’s common stock, par value $0.001 per share (the “Shares”), in the amounts, at such times and at the price per share set forth in Section 1. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. This Warrant is issued in connection with the transactions described in the Term Loan Agreement, dated as of December 30, 2016 (the “Term Loan Agreement”), by and between the Company, the Subsidiary Guarantors from time to time party thereto, the Lenders from time to time party thereto and CRG Servicing LLC.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF T2 BIOSYSTEMS, INC. Dated as of December 30, 2016 Void after the date specified in Section 8Warrant Agreement • March 15th, 2017 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS CERTIFIES THAT, for value received, CRG PARTNERS III (CAYMAN) L.P. or its registered assigns (the “Holder”), is entitled, subject to the provisions and upon the terms and conditions set forth herein, to purchase from T2 Biosystems, Inc., a Delaware corporation (the “Company”), shares of the Company’s common stock, par value $0.001 per share (the “Shares”), in the amounts, at such times and at the price per share set forth in Section 1. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. This Warrant is issued in connection with the transactions described in the Term Loan Agreement, dated as of December 30, 2016 (the “Term Loan Agreement”), by and between the Company, the Subsidiary Guarantors from time to time party thereto, the Lenders from time to time party thereto and CRG Servicing LLC.
